Literature DB >> 1849126

Ocular toxicity of experimental intravitreal itraconazole.

J A Schulman1, G A Peyman, J Dietlein, R Fiscella.   

Abstract

We investigated itraconazole, a new triazole antifungal agent that poorly penetrates ocular tissues after oral administration. We injected itraconazole in doses from 10 to 100 micrograms dissolved in 100% dimethyl sulfoxide into the eyes of New Zealand rabbits. Ocular toxicity studies performed five weeks after administration showed no substantial retinal or histopathologic changes in eyes injected with either 100% dimethyl sulfoxide or 10 micrograms of itraconazole. Higher doses caused focal areas of retinal necrosis. Our results indicated that intravitreal doses of 10 micrograms or less of itraconazole may be beneficial in the treatment of fungal endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849126     DOI: 10.1007/bf00150975

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  15 in total

1.  Exogenous intraocular fungus infections with particular reference to complications of intraocular surgery.

Authors:  B S FINE; L E ZIMMERMAN
Journal:  Am J Ophthalmol       Date:  1959-08       Impact factor: 5.258

2.  OCULAR PENETRATION OF AMPHOTERICIN B: A REPORT OF LABORATORY STUDIES AND A CASE REPORT OF POSTSURGICAL CEPHALOSPORIUM ENDOPHTHALMITIS.

Authors:  W R GREEN; J E BENNETT; R D GOOS
Journal:  Arch Ophthalmol       Date:  1965-06

3.  The activity of ketoconazole and itraconazole against Aspergillus fumigatus in mixed cultures with macrophages or leukocytes.

Authors:  F Aerts; J Van Cutsem; M De Brabander
Journal:  Mykosen       Date:  1986-04

4.  Intravitreal amphotericin B toxicity.

Authors:  E N Souri; W R Green
Journal:  Am J Ophthalmol       Date:  1974-07       Impact factor: 5.258

5.  Comparison of itraconazole and ketoconazole in the treatment of experimental candidal vaginitis.

Authors:  J D Sobel; G Muller
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  Itraconazole in the treatment of human mycoses: review of three years of clinical experience.

Authors:  G Cauwenbergh; P De Doncker; K Stoops; A M De Dier; H Goyvaerts; V Schuermans
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

7.  Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.

Authors:  J R Perfect; D V Savani; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

8.  Toxicity of intravitreous miconazole.

Authors:  F I Tolentino; C S Foster; M Lahav; L H Liu; A R Rabin
Journal:  Arch Ophthalmol       Date:  1982-09

9.  Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis model.

Authors:  A Polak; F C Odds; E Lüdin; H J Scholer
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

10.  Vitrectomy in experimental endophthalmitis: Part I-Fungal infection.

Authors:  K Huang; G A Peyman; J McGetrick
Journal:  Ophthalmic Surg       Date:  1979-03
View more
  4 in total

Review 1.  Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.

Authors:  Prit Lakhani; Akash Patil; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2018-11-08       Impact factor: 2.671

Review 2.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

3.  Dimethyl sulphoxide dose-response on rat retinal function.

Authors:  Tina I Tsai; Bang V Bui; Algis J Vingrys
Journal:  Doc Ophthalmol       Date:  2009-09-11       Impact factor: 2.379

4.  Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.

Authors:  Jeong Hun Bae; Ah Reum Hwang; Chan Yun Kim; Hyeong Gon Yu; Hyoung Jun Koh; Woo Ick Yang; Hae Ran Chang; Sung Chul Lee
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.